828 WINTER STREET, WALTHAM, MA
Market cap: $35.1M (12/18/2025)
Price: $0.67
Xilio Therapeutics Stockholders Approve 2025 Stock Incentive Plan
Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Xilio Therapeutics Begins Phase 2 Trial for Efarindodekin Alfa, Achieves $17.5M Milestone with Gilead
Announces Pipeline and Business Updates and Second Quarter 2025 Financial Results
Shareholder votes
Changes in Board, Management or Compensation
Q3
Q2
Q1
FY 2024
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Correspondence